November 21, 2025 3 min read
Glutathione — your body's most abundant and important intracellular antioxidant — declines approximately 10% per decade after age 20, and this progressive decline correlates directly with increased oxidative damage, reduced detoxification capacity, and accelerated biological aging.
Glutathione is a tripeptide synthesized from three amino acids: glycine, cysteine, and glutamate. Its production depends on the enzyme glutamate-cysteine ligase (GCL), which declines in activity with age. Simultaneously, oxidative demands increase as mitochondrial efficiency drops — meaning you need more glutathione at exactly the time your body produces less of it.
By age 60, most adults have approximately 40% less glutathione than they had at age 20. This decline is not just a biomarker — it's functionally consequential. Low glutathione status is associated with increased susceptibility to infection, impaired detoxification of environmental toxins, accelerated mitochondrial damage, increased DNA mutation rates, and reduced exercise recovery capacity.
Two complementary approaches: direct supplementation with reduced (L-) glutathione, and precursor supplementation that supports endogenous production. L-Glutathione provides Setria® reduced glutathione — a clinically studied form shown to raise blood glutathione levels. GlyNAC+ provides glycine and N-acetyl cysteine (NAC) — the two amino acid precursors that are most commonly rate-limiting for glutathione synthesis. The GlyNAC combination has demonstrated significant improvements in oxidative stress markers, mitochondrial function, and inflammation in clinical trials at Baylor College of Medicine.
Some of the most compelling research on glutathione repletion in aging comes from the Baylor College of Medicine GlyNAC studies led by Dr. Rajagopal Sekhar. These trials supplemented older adults with glycine (100mg/kg/day) and N-acetyl cysteine (100mg/kg/day) — the two amino acid precursors most commonly rate-limiting for glutathione synthesis.
The results were striking: GlyNAC supplementation corrected glutathione deficiency within 2 weeks, reduced oxidative stress markers (F2-isoprostanes), lowered inflammatory markers (IL-6, TNF-alpha), improved mitochondrial fatty acid oxidation, reduced insulin resistance, improved physical function (gait speed, grip strength), and reduced waist circumference — all in adults aged 61-80. Many of these benefits reversed when supplementation was stopped, confirming that the improvements were caused by the intervention rather than other factors.
These findings suggest that much of the functional decline attributed to "normal aging" may actually be modifiable glutathione deficiency — and that providing the body with adequate precursors allows it to restore its own glutathione production rather than relying solely on exogenous glutathione supplementation.
Glutathione is synthesized from three amino acids: glycine, cysteine, and glutamate. Glutamate is rarely limiting — it's abundant in most diets. Cysteine is the classical rate-limiting precursor, which is why NAC (N-acetyl cysteine, a bioavailable cysteine donor) has long been used to support glutathione production. But the Baylor research revealed that glycine depletion in aging is equally significant — and had been largely overlooked. Glycine requirements appear to exceed dietary supply in older adults, making it a co-limiting precursor that must be supplemented alongside cysteine for optimal glutathione restoration.
Is oral glutathione effectively absorbed?
Earlier research questioned oral glutathione absorption, but studies using Setria® reduced glutathione have demonstrated significant increases in blood and tissue glutathione levels with oral supplementation at 250–1,000mg daily. The form matters — reduced (L-) glutathione is the active form.
Should I take glutathione or its precursors?
Both have value. Direct supplementation provides immediate glutathione. Precursors (GlyNAC) support your body's ongoing production capacity. Many practitioners recommend combining both approaches for comprehensive support, especially after age 40 when endogenous production significantly declines.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Comments will be approved before showing up.
May 15, 2026 4 min read
Read MoreSign up to get the latest on sales, new releases and more …
Sign up and get the latest on sales, new releases, and more...